These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7587026)

  • 1. Selection of cephalosporins for hospital formularies.
    Wilson WR
    Diagn Microbiol Infect Dis; 1995; 22(1-2):129-34. PubMed ID: 7587026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime and ceftriaxone use evaluation in pediatrics. Considerations of cost effectiveness.
    Lee CK; Glenn DJ
    Diagn Microbiol Infect Dis; 1995; 22(1-2):231-3. PubMed ID: 7587045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third generation cephalosporins in the parenteral to oral switch.
    Rimmer D
    Pharmacoeconomics; 1994; 5(Suppl 2):27-33. PubMed ID: 10147286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.
    Nathwani D
    Drugs; 2000; 59 Suppl 3():37-46; discussion 47-9. PubMed ID: 10845412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symposium on antimicrobial therapy. IV. The cephalosporins.
    Greenfield RA
    J Okla State Med Assoc; 1993 Jan; 86(1):7-12. PubMed ID: 8426246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential therapy with intravenous and oral cephalosporins.
    Janknegt R; van der Meer JW
    J Antimicrob Chemother; 1994 Jan; 33(1):169-77. PubMed ID: 8157558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009).
    Versporten A; Coenen S; Adriaenssens N; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
    J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi25-35. PubMed ID: 22096063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
    Esposito S
    Drugs; 2000; 59 Suppl 3():19-28; discussion 47-9. PubMed ID: 10845410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital.
    Bamberger DM; Dahl SL
    Arch Intern Med; 1992 Mar; 152(3):554-7. PubMed ID: 1546918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins.
    Tice AD
    Drugs; 2000; 59 Suppl 3():29-35; discussion 47-9. PubMed ID: 10845411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephalosporin, carbapenem, and monobactam antibiotics.
    Thompson RL
    Mayo Clin Proc; 1987 Sep; 62(9):821-34. PubMed ID: 3306182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audit of first generation cephalosporin usage.
    Shetty N; Shulman RI; Scott GM
    J Hosp Infect; 1999 Mar; 41(3):229-32. PubMed ID: 10204126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cephalosporin antibiotics in pediatric practice.
    Ross S; Rodriguez W; Khan W
    South Med J; 1977 Jul; 70(7):855-61. PubMed ID: 877649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin antibiotics.
    Thompson RL; Wright AJ
    Mayo Clin Proc; 1983 Feb; 58(2):79-87. PubMed ID: 6401833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cefixime, the first oral third-generation cephalosporin].
    Roche G
    Presse Med; 1989 Oct; 18(32):1541-4. PubMed ID: 2530527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
    Neu HC
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use.
    Strehl E; Kees F
    Drugs; 2000; 59 Suppl 3():9-18; discussion 47-9. PubMed ID: 10845409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.